Target intelligence / Profile preview

Solute carrier family 25 member 17 (SLC25A17)

Target
SLC25A17
Molecular classification
Transporter, Solute carrier (SLC) family protein, Peroxisomal membrane protein
01

Overview

Solute carrier family 25 member 17 (SLC25A17), commonly referred to as peroxisomal membrane protein PMP34, is a peroxisomal membrane transporter and member of the mitochondrial carrier (solute carrier, SLC) family[2][3][6]. SLC25A17 facilitates the import of essential cofactors—including coenzyme A (CoA), flavin adenine dinucleotide (FAD), flavin mononucleotide (FMN), and adenosine monophosphate (AMP)—from the cytosol into the peroxisomal matrix, primarily via a counter-exchange transport mechanism[2][3][6]. This activity is essential to equip peroxisomes for various metabolic processes such as fatty acid β-oxidation and to maintain cellular metabolic homeostasis[2][4][6]. SLC25A17 also plays a role in maintaining the peroxisomal redox balance[2]. Mutations or deficiencies in SLC25A17 are associated with peroxisomal dysfunction, altered lipid composition, and developmental defects in model organisms, and disruptions in its activity may contribute to metabolic and neurodevelopmental disorders[4][3]. Emerging evidence suggests it may have clinical relevance as a biomarker in certain cancers, but no direct therapeutic drugs are known to interact with this target[2][3][1].

Other names
Peroxisomal membrane protein PMP34PMP34Solute carrier family 25 (mitochondrial carrier; peroxisomal membrane protein, 34kDa), member 17Peroxisomal membrane protein (34kD)34 kDa peroxisomal membrane protein
02

Biological functions

Transport of cofactors (coenzyme A, FAD, FMN, AMP) into the peroxisomeMaintenance of peroxisomal and cellular metabolic functionsRegulation of peroxisomal redox environment
03

Disease associations

Peroxisomal diseaseZellweger syndromeCancer (notably as a potential prognostic biomarker in head and neck squamous cell carcinoma)
04

Biomarkers

SLC25A17 expression (as a potential prognostic biomarker in head and neck squamous cell carcinoma)

Beyond the preview

Go deeper on Solute carrier family 25 member 17 (SLC25A17).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Solute carrier family 25 member 17 (SLC25A17).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call